UR announces PharmAdva will join START-UP NY
PharmAdva is commercializing a technology developed at the University of Rochester Medical Center by Michel Berg, M.D. The company will be making automated home pill dispensers that prompt patients to take their medications on time and in the proper doses.
Implantable diagnostic technology advances
The University has received a second patent for an implantable biosensor that can provide physicians with real time information on their patients’ health.
Statement from President Seligman regarding New York State’s approval of its START-UP NY plan
On Tuesday, the New York State START-UP NY program board approved the University of Rochester’s plan to designate 105,894 square feet of tax free space at High Tech Rochester’s Lennox…
University of Rochester previews new data visualization lab
The new VISTA Collaboratory, located in the Carlson Science and Engineering Library, completes a high performance supercomputing system on a massive scale and is one of only a handful of similar labs in the U.S. The display consists of an array of 24 monitors, is 20 feet wide and 8 feet tall, and has a resolution approaching that of IMAX theaters.
New report details economic reach of University
A new report by the Center for Governmental Research (CGR) shows that the University is directly and indirectly responsible for supporting an estimated 50,300 jobs in the region. The report also finds that the new Institute for Data Science will create 460 jobs, and with 22,451 full-time-equivalent (FTE) employees, the University is the eighth largest private sector employer in the state.
Seligman, Wegman React to Finger Lakes Economic Funding
Governor Andrew Cuomo and legislative leaders announced $59.8 million in economic development support for the nine-county Finger Lakes region.
New Report Highlights UR Start-Ups
New ideas and technologies produced at research universities are essential to U.S. industry and its ability to compete globally.
Kieburtz to Oversee URMC Clinical Research
Karl Kieburtz, the Robert J. Joynt Professor in Neurology, is the director of the Center for Human Experimental Therapeutics (CHET), a position he will retain.
Statement on START-UP NY Legislation
President Seligman gives a statement thanking government leaders for their efforts in creating the START-UP NY plan.
University Inaugurates New Era of Health Care Research
The new IBM Blue Gene/Q supercomputer unveiled last week at the University’s Health Sciences Center for Computational Innovation (HSCCI) is one of the nation’s five most powerful university-based supercomputing sites.